Home - Products - Others - Other Targets - 25R-Spirostan-4-ene-3,6,12-trione

25R-Spirostan-4-ene-3,6,12-trione

CAS No. 214681-62-6

25R-Spirostan-4-ene-3,6,12-trione( ——— )

Catalog No. M38116 CAS No. 214681-62-6

(25R)-Spirost-4-ene-3,6,12-trione is a natural product, that can be isolated from T. terrestris L.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    25R-Spirostan-4-ene-3,6,12-trione
  • Note
    Research use only, not for human use.
  • Brief Description
    (25R)-Spirost-4-ene-3,6,12-trione is a natural product, that can be isolated from T. terrestris L.
  • Description
    (25R)-Spirost-4-ene-3,6,12-trione is a natural product, that can be isolated from T. terrestris L.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    214681-62-6
  • Formula Weight
    440.57
  • Molecular Formula
    C27H36O5
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xu Y X, et al. Two sapogenins from Tribulus terrestris. Phytochemistry, 1998, 49(1):199-201.
molnova catalog
related products
  • L-BORNYL ACETATE

    L-BORNYL ACETATE

  • Hydroxy-ε-sanshool

    Hydroxy-Epsilon-Sanshool is an alkylamide isolated from Zanthoxylum bungeanum. Hydroxy-Epsilon-Sanshool produces key tingling and numbing chemosensates, and its content is important in determinant the pungency intensity of Zanthoxylum bungeanum.

  • Disitamab vedotin

    Disitamab vedotin (RC-48) is a newly developed antibody-active molecule conjugate (ADC) targeting human epidermal growth factor receptor 2 (HER2), consisting of hertuzumab coupled to monomethyl auristatin E (MMAE) via a cleavable linker.